| 1 |
Diagnostic potential of serum humanin in breast cancer among the Egyptian population |
2026 |
| 2 |
Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute |
2025 |
| 3 |
Klotho and LRP6 as Emerging Biomarkers in Gastric Adenocarcinoma: Expression Patterns and Clinical Relevance |
2025 |
| 4 |
Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters |
2025 |
| 5 |
Predictive and Prognostic Significance of Serum Neuron Specific Enolase in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Gefitinib: A Prospective Study from South Egypt Cancer Institute |
2025 |
| 6 |
Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients |
2025 |
| 7 |
Role of immunohistochemistry in molecular classification, prognosis, and survival of colorectal cancer patients |
2025 |
| 8 |
Prognostic significance of the tumor budding and tumor-infiltrating lymphocytes in survival of hepatocellular carcinoma patients |
2024 |
| 9 |
Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer |
2024 |
| 10 |
Outcome of Anthracycline versus Taxane Based Regimens on Different Metastatic Sites in Breast Cancer |
2024 |
